Aurrigo's 160% Surge, Oxford Drug Design Funding, Fossil-Free Fuel at National Oceanography Centre
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on December 06, 2024 11:10 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 442961240 series 3522529
These are the top stories making the headlines across The Business Magazine website today:
Aurrigo International sees strong growth in autonomous division in first half
Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.
Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/
Oxford Drug Design set to help advance new treatments for CF lung infections
Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.
Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/
Southampton’s National Oceanography Centre trials low-carbon fuel
On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.
Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/
257 에피소드